Avi Schroeder is a Professor of Chemical Engineering at the Technion–Israel Institute of Technology, where he heads the Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies (https://www.schroederlab.com/ ). Dr. Schroeder conducted his Postdoctoral studies at the Massachusetts Institute of Technology (MIT), and his PhD jointly at the Hebrew and Ben Gurion Universities. Avi is the recipient of more than 40 national and international recognitions, including being named a Fellow of the Royal Society of Chemistry, a KAVLI Fellow, and being awarded the Intel Nanotechnology Award, the TEVA Pharmaceuticals Award, and the Wolf Foundation Krill Award. Avi is the author of 100 papers, the inventor of 25 patents, and the co-founder of multiple startups based on these discoveries. Schroeder is the recipient of ERC-StG, ERC-CoG, and ERC-POC grants. Schroeder is a former President of the Controlled Release Society (CRS).